TVTX
Travere Therapeutics Inc
52.00$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +21.5% | -8.2% | +30.8% | +16.2% | +18.9% | +9.3% | +40.0% | +44.0% | -21.3% | -1.9% | +33.3% | – | |
| – | +1,173.5% | -90.8% | +724.9% | -86.9% | +57.0% | +83.3% | -67.5% | +4.2% | +61.1% | +948.4% | -91.9% | – | |
| – | -20.0% | +39.2% | +4.6% | +46.9% | +17.9% | +6.7% | +46.6% | +44.6% | -22.1% | -21.0% | +66.7% | – | |
| – | -3.0% | +95.1% | -52.6% | -4.9% | +20.1% | -24.5% | +5.3% | +5.1% | +11.5% | -1.3% | +5.6% | – | |
| – | -6.2% | +1.0% | +0.9% | +1.3% | +5.9% | +4.8% | +4.6% | +13.4% | +17.6% | -21.1% | +19.8% | – | |
| – | -13.2% | +60.7% | -39.3% | +8.0% | +13.2% | -10.0% | +4.9% | +10.2% | +15.3% | -13.9% | +19.0% | – | |
| – | – | – | – | – | – | – | – | – | -230.1% | – | – | – | |
| – | +0.0% | -0.7% | -0.4% | -0.4% | +1.4% | +1.4% | -0.4% | -3.3% | -16.5% | +0.2% | -7.2% | – | |
| – | – | – | – | – | – | – | – | – | -181.9% | – | – | – | |
| – | +466.7% | +180.9% | -55.5% | -198.8% | – | – | -48.7% | -60.0% | +11,412.5% | -113.0% | – | – | |
| – | -159.8% | – | – | – | – | – | – | – | -89.4% | -1,459.5% | – | – | |
| – | – | – | – | – | – | – | – | +972.3% | -101.4% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.